US Stock MarketDetailed Quotes

CRXM Gene Biotherapeutics

Watchlist

0.000001
0.0000000.00%

15min DelayClose Feb 9 16:00 ET

64.93Market Cap0.00P/E (TTM)

Gene Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

(Q1)Mar 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-726.03%-1.13M

-1,344.48%-337.87K

-671.70%-479.8K

-1,868.05%-221.48K

-132.64%-93.86K

69.62%-137.16K

-23.39K

-62.17K

-11.25K

-40.34K

Net income from continuing operations

-183.63%-651.55K

-134.14%-489.51K

-166.79%-401.41K

262.40%408.18K

33.30%-168.81K

240.96%779.13K

--1.43M

---150.46K

---251.33K

---253.11K

Operating gains losses

---600K

--0

----

Depreciation and amortization

-96.88%1.82K

-93.66%656

-97.68%370

-97.36%421

-7.95%58.18K

--10.35K

--15.94K

Other non cash items

96.23%-62.92K

95.85%-68.98K

2,775.78%72.81K

----

-17,268.78%-1.67M

---1.66M

---2.72K

Change In working capital

-74.18%179.65K

13.23%219.96K

-301.93%-151.57K

-83.81%36.72K

-62.65%74.54K

12.64%695.72K

--194.25K

--75.06K

--226.86K

--199.54K

-Change in prepaid assets

157.96%7.78K

65.22%-5.44K

129.58%1.25K

9,203.57%104.11K

-1,836.76%-92.14K

-175.44%-13.43K

---15.63K

---4.22K

--1.12K

--5.31K

-Change in payables and accrued expense

-74.77%178.94K

7.39%225.4K

-292.77%-152.84K

-126.71%-60.29K

-14.19%166.67K

18.22%709.15K

--209.89K

--79.28K

--225.74K

--194.24K

-Change in other current assets

---7.07K

--0

--19

----

--0

----

Cash from discontinued investing activities

Operating cash flow

-726.03%-1.13M

-1,344.42%-337.87K

-671.72%-479.8K

-1,868.05%-221.48K

-132.64%-93.86K

69.62%-137.16K

---23.39K

---62.17K

---11.25K

---40.34K

Investing cash flow

Cash flow from continuing investing activities

-3.43K

-4

Net PPE purchase and sale

---3.43K

---4

----

--0

----

Cash from discontinued investing activities

Investing cash flow

---3.43K

---4

----

--0

----

Financing cash flow

Cash flow from continuing financing activities

2,645.08%1.52M

-328.27%-57.68K

-148.10%-47.67K

21,259.25%1.53M

357.94%96.38K

133.53%55.45K

-13.47K

99.11K

7.17K

-37.37K

Net issuance payments of debt

-119.92%-11.04K

-114.44%-192.2K

-90.42%12.33K

34.84%72.45K

357.94%96.38K

133.53%55.45K

---89.63K

--128.71K

--53.73K

---37.37K

Net preferred stock issuance

--1.7M

--0

----

--0

----

Net other financing activities

---166.89K

--134.53K

-102.70%-60K

----

---29.6K

----

Cash from discontinued financing activities

Financing cash flow

2,645.08%1.52M

-328.27%-57.68K

-148.10%-47.67K

21,259.25%1.53M

357.94%96.38K

133.53%55.45K

---13.47K

--99.11K

--7.17K

---37.37K

Net cash flow

Beginning cash position

-99.51%400

1,997.73%781.57K

411,333.54%1.31M

-33.58%2.93K

-99.51%400

67.62%82.12K

--37.26K

--319

--4.41K

--82.12K

Current changes in cash

571.92%385.63K

-973.16%-395.54K

-1,537.24%-530.9K

32,149.61%1.31M

103.25%2.53K

-346.68%-81.72K

---36.86K

--36.94K

---4.09K

---77.71K

End cash Position

96,406.75%386.03K

1,997.73%781.57K

411,333.54%1.31M

-33.58%2.93K

-99.51%400

--400

--37.26K

--319

--4.41K

Free cash flow

-728.54%-1.14M

-1,344.44%-337.87K

-677.23%-483.23K

-1,868.05%-221.48K

-132.64%-93.86K

69.62%-137.16K

---23.39K

---62.17K

---11.25K

---40.34K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019	(Q1)Mar 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-726.03%-1.13M	-1,344.48%-337.87K	-671.70%-479.8K	-1,868.05%-221.48K	-132.64%-93.86K	69.62%-137.16K	-23.39K	-62.17K	-11.25K	-40.34K
Net income from continuing operations	-183.63%-651.55K	-134.14%-489.51K	-166.79%-401.41K	262.40%408.18K	33.30%-168.81K	240.96%779.13K	--1.43M	---150.46K	---251.33K	---253.11K
Operating gains losses	---600K	--0	--0	----	----	----	----	----	----	----
Depreciation and amortization	-96.88%1.82K	-93.66%656	-97.68%370	-97.68%370	-97.36%421	-7.95%58.18K	--10.35K	--15.94K	--15.94K	--15.94K
Other non cash items	96.23%-62.92K	95.85%-68.98K	2,775.78%72.81K	----	----	-17,268.78%-1.67M	---1.66M	---2.72K	---2.72K	---2.72K
Change In working capital	-74.18%179.65K	13.23%219.96K	-301.93%-151.57K	-83.81%36.72K	-62.65%74.54K	12.64%695.72K	--194.25K	--75.06K	--226.86K	--199.54K
-Change in prepaid assets	157.96%7.78K	65.22%-5.44K	129.58%1.25K	9,203.57%104.11K	-1,836.76%-92.14K	-175.44%-13.43K	---15.63K	---4.22K	--1.12K	--5.31K
-Change in payables and accrued expense	-74.77%178.94K	7.39%225.4K	-292.77%-152.84K	-126.71%-60.29K	-14.19%166.67K	18.22%709.15K	--209.89K	--79.28K	--225.74K	--194.24K
-Change in other current assets	---7.07K	--0	--19	----	----	--0	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-726.03%-1.13M	-1,344.42%-337.87K	-671.72%-479.8K	-1,868.05%-221.48K	-132.64%-93.86K	69.62%-137.16K	---23.39K	---62.17K	---11.25K	---40.34K
Investing cash flow
Cash flow from continuing investing activities	-3.43K	-4				0	0
Net PPE purchase and sale	---3.43K	---4	----	----	----	--0	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	---3.43K	---4	----	----	----	--0	--0	----	----	----
Financing cash flow
Cash flow from continuing financing activities	2,645.08%1.52M	-328.27%-57.68K	-148.10%-47.67K	21,259.25%1.53M	357.94%96.38K	133.53%55.45K	-13.47K	99.11K	7.17K	-37.37K
Net issuance payments of debt	-119.92%-11.04K	-114.44%-192.2K	-90.42%12.33K	34.84%72.45K	357.94%96.38K	133.53%55.45K	---89.63K	--128.71K	--53.73K	---37.37K
Net preferred stock issuance	--1.7M	--0	--0	----	----	--0	--0	--0	----	----
Net other financing activities	---166.89K	--134.53K	-102.70%-60K	----	----	----	----	---29.6K	----	----
Cash from discontinued financing activities
Financing cash flow	2,645.08%1.52M	-328.27%-57.68K	-148.10%-47.67K	21,259.25%1.53M	357.94%96.38K	133.53%55.45K	---13.47K	--99.11K	--7.17K	---37.37K
Net cash flow
Beginning cash position	-99.51%400	1,997.73%781.57K	411,333.54%1.31M	-33.58%2.93K	-99.51%400	67.62%82.12K	--37.26K	--319	--4.41K	--82.12K
Current changes in cash	571.92%385.63K	-973.16%-395.54K	-1,537.24%-530.9K	32,149.61%1.31M	103.25%2.53K	-346.68%-81.72K	---36.86K	--36.94K	---4.09K	---77.71K
End cash Position	96,406.75%386.03K	96,406.75%386.03K	1,997.73%781.57K	411,333.54%1.31M	-33.58%2.93K	-99.51%400	--400	--37.26K	--319	--4.41K
Free cash flow	-728.54%-1.14M	-1,344.44%-337.87K	-677.23%-483.23K	-1,868.05%-221.48K	-132.64%-93.86K	69.62%-137.16K	---23.39K	---62.17K	---11.25K	---40.34K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall